Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Nordhausen

12 clinical trials in Nordhausen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Nordhausen at a glance
12
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Nordhausen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut fuer Frauengesundheit GmbH

Colitis ulcerative

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Rosnilimab
  • Sponsor:Anaptysbio Inc.

Colitis ulcerative

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Crohn's disease

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH

Colitis ulcerative

Not recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tamuzimod Acetate
  • Sponsor:Oppilan Pharma Limited
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Breast cancer

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Doxorubicin
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm malignant

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Nordhausen

What the registry says about research in the country

01 Breast Cancer Research

Comprehensive studies focusing on various types of breast cancer, particularly investigating treatments for HER2-negative and hormone receptor-positive variants. These trials aim to evaluate new therapeutic approaches and improve patient outcomes.

  • Triple-Negative Breast Cancer Treatment
  • Early-Stage ER+/HER2- Cancer Therapy
  • Advanced Breast Cancer Management

Multiple innovative therapies are being tested, including immunotherapy combinations and targeted treatments.

02 Gastrointestinal Disorders

Research focusing on inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis. These studies evaluate novel therapeutic agents aimed at managing moderate to severe disease manifestations.

  • Ulcerative Colitis Treatment Options
  • Crohn's Disease Management
  • Long-term Disease Control

Trials investigate both established and experimental treatments to improve patient quality of life.

03 Gynecologic Oncology

Studies examining treatment strategies for advanced ovarian cancer, including combination therapies and novel drug applications. Research focuses on improving survival rates and treatment effectiveness.

  • Advanced Ovarian Cancer Therapy
  • Peritoneal Cancer Treatment
  • Fallopian Tube Cancer Research

Innovative approaches combine standard chemotherapy with targeted biological agents.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.